• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Information Technology Stocks Moving In Thursday's Pre-Market Session

    2/1/24 8:05:59 AM ET
    $AEY
    $AKTS
    $BLBX
    $CETX
    Office Equipment/Supplies/Services
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEY alert in real time by email

    Gainers

    • Blackboxstocks (NASDAQ:BLBX) shares moved upwards by 45.1% to $4.7 during Thursday's pre-market session. The company's market cap stands at $15.1 million.
    • Minim (NASDAQ:MINM) stock increased by 15.85% to $4.75. The market value of their outstanding shares is at $13.7 million.
    • Akoustis Technologies (NASDAQ:AKTS) stock rose 11.59% to $0.64. The market value of their outstanding shares is at $63.1 million.
    • Edgio (NASDAQ:EGIO) stock moved upwards by 8.07% to $0.28. The market value of their outstanding shares is at $65.8 million.
    • Cheetah Mobile (NYSE:CMCM) shares rose 7.28% to $2.21. The company's market cap stands at $66.1 million.
    • Qorvo (NASDAQ:QRVO) shares moved upwards by 6.27% to $106.0. The market value of their outstanding shares is at $10.3 billion. The company's, Q3 earnings came out yesterday.

    Losers

    • Infobird Co (NASDAQ:IFBD) shares fell 28.7% to $0.97 during Thursday's pre-market session. The company's market cap stands at $7.2 million.
    • Addvantage Technologies (NASDAQ:AEY) shares fell 16.22% to $1.55. The company's market cap stands at $2.3 million.
    • Cemtrex (NASDAQ:CETX) stock declined by 12.2% to $3.6. The market value of their outstanding shares is at $3.8 million.
    • MaxLinear (NASDAQ:MXL) stock declined by 11.39% to $18.45. The company's market cap stands at $1.5 billion. As per the press release, Q4 earnings came out yesterday.
    • CCSC Technology (NASDAQ:CCTG) shares decreased by 10.34% to $19.0. The market value of their outstanding shares is at $216.1 million.
    • Remark Hldgs (NASDAQ:MARK) shares fell 9.07% to $0.59. The company's market cap stands at $12.2 million. See Also: www.benzinga.com/money/tech-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AEY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEY
    $AKTS
    $BLBX
    $CETX

    CompanyDatePrice TargetRatingAnalyst
    Qorvo Inc.
    $QRVO
    4/22/2026$100.00Equal Weight → Overweight
    Barclays
    Qorvo Inc.
    $QRVO
    4/20/2026$66.00Neutral → Underperform
    Mizuho
    Qorvo Inc.
    $QRVO
    4/17/2026Outperform → Peer Perform
    Wolfe Research
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$30.00Overweight
    Analyst
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$34.00Buy
    BofA Securities
    Aktis Oncology Inc.
    $AKTS
    2/3/2026$31.00Outperform
    Leerink Partners
    Aktis Oncology Inc.
    $AKTS
    2/3/2026Buy
    TD Cowen
    More analyst ratings

    $AEY
    $AKTS
    $BLBX
    $CETX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cheetah Mobile Files 2025 Annual Report on Form 20-F

    BEIJING, April 23, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE:CMCM), a China-based IT company with a commitment to AI innovation, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on April 23, 2026. The annual report can be accessed on the Company's investor relations website at http://ir.cmcm.com or the SEC's website at www.sec.gov. About Cheetah Mobile Inc.Cheetah Mobile is a China-based IT company with a commitment to AI innovation. It has developed and launched a diversified suite of software products for PCs and mobile devices, designed to address u

    4/23/26 8:00:00 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    Qorvo® to Distribute Quarterly Earnings on May 5, 2026

    GREENSBORO, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Qorvo® (NASDAQ:QRVO), a leading global provider of connectivity and power solutions, will distribute fiscal 2026 fourth quarter financial results at approximately 4:00 p.m. (ET) on Tuesday, May 5, 2026. The press release will be available on the Company's Investor Relations website at the following URL: https://ir.qorvo.com (under "Financial Releases"). Given Qorvo's pending transaction with Skyworks, Qorvo has discontinued conducting conference calls and providing forward-looking guidance. About QorvoQorvo (NASDAQ:QRVO) supplies innovative semiconductor solutions that make a better world possible. We combine product and technology lea

    4/21/26 8:03:00 AM ET
    $QRVO
    Semiconductors
    Technology

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEY
    $AKTS
    $BLBX
    $CETX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Foley Todd converted options into 4,002,533 shares and bought $4,191,660 worth of shares (232,870 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:20:21 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Mpm Bioventures 2018, L.P. converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:19:26 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Gadicke Ansbert converted options into 8,805,578 shares and bought $20,029,986 worth of shares (1,112,777 units at $18.00) (SEC Form 4)

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    1/14/26 6:17:54 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEY
    $AKTS
    $BLBX
    $CETX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Qorvo upgraded by Barclays with a new price target

    Barclays upgraded Qorvo from Equal Weight to Overweight and set a new price target of $100.00

    4/22/26 7:43:34 AM ET
    $QRVO
    Semiconductors
    Technology

    Qorvo downgraded by Mizuho with a new price target

    Mizuho downgraded Qorvo from Neutral to Underperform and set a new price target of $66.00

    4/20/26 8:24:56 AM ET
    $QRVO
    Semiconductors
    Technology

    Qorvo downgraded by Wolfe Research

    Wolfe Research downgraded Qorvo from Outperform to Peer Perform

    4/17/26 8:09:01 AM ET
    $QRVO
    Semiconductors
    Technology

    $AEY
    $AKTS
    $BLBX
    $CETX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gormley Glenn

    4 - Aktis Oncology, Inc. (0002035832) (Issuer)

    4/16/26 4:15:09 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Gormley Glenn

    3 - Aktis Oncology, Inc. (0002035832) (Issuer)

    4/16/26 4:05:08 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Peng Bo Polly

    3 - Cheetah Mobile Inc. (0001597835) (Issuer)

    3/27/26 7:37:53 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    $AEY
    $AKTS
    $BLBX
    $CETX
    SEC Filings

    View All

    SEC Form 10-Q filed by MaxLinear Inc.

    10-Q - MAXLINEAR, INC (0001288469) (Filer)

    4/23/26 4:13:32 PM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - MAXLINEAR, INC (0001288469) (Filer)

    4/23/26 4:07:47 PM ET
    $MXL
    Semiconductors
    Technology

    SEC Form 20-F filed by Cheetah Mobile Inc.

    20-F - Cheetah Mobile Inc. (0001597835) (Filer)

    4/23/26 7:12:09 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    $AEY
    $AKTS
    $BLBX
    $CETX
    Leadership Updates

    Live Leadership Updates

    View All

    Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the "Company"), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company's newly established Science and Technology Committee of the Board of Directors. "We are delighted to welcome Glenn to our Board as we continue to make significant progress toward upcoming clinical and corporate milestones," said Matthew Roden, PhD, President a

    4/16/26 8:00:00 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target, REalloys to Appoint Bob Foresman to its Board of Directors

    Following the Addition of General Jack Keane, REalloys Further Strengthens Board with Addition of Former Vice Chairman of UBS Investment Bank  Blackboxstocks/REalloys Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close the merger DALLAS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has entered into a designate director agreement with Bob Foresman. Mr. Foresman will formally join the REalloys Board of Directors upon the closing of the merger between Blackboxstocks and REalloys. Blackboxstocks' regist

    2/18/26 8:00:00 AM ET
    $BLBX
    EDP Services
    Technology

    Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys, to Appoint General Jack Keane to its Board of Directors

    General Keane, a Four-Star General (Ret), Joins REalloys on its Mission to Scale North-America's Most Advanced Heavy Rare Earth Supply Chain & Technology Platform REalloys' Form S-4 has been declared effective by the SEC, and, pending NASDAQ listing approval, the company expects to close its merger with Blackboxstocks, Inc. (NASDAQ:BLBX) DALLAS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ:BLBX) ("Blackboxstocks" or the "Company") today announced that its merger target, REalloys Inc. ("REalloys"), has appointed General John M. "Jack" Keane (U.S. Army, Ret.) as a Designate Director. General Keane will formally join the Board of Directors upon the closing of the merger b

    2/9/26 8:30:00 AM ET
    $BLBX
    EDP Services
    Technology

    $AEY
    $AKTS
    $BLBX
    $CETX
    Financials

    Live finance-specific insights

    View All

    MaxLinear, Inc. Announces Conference Call to Review First Quarter 2026 Financial Results

    Thursday, April 23, 2026 at 1:30 p.m. Pacific Time; 4:30 p.m. Eastern Time MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, announced today that it will release its financial results for the first quarter 2026 after the close of market on Thursday, April 23, 2026. The company will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date:   April 23, 2026 Time:   1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Hosts:   Kishore Seendripu, Ph.D., Chief Executive Officer and Steve Litchfield, Chief Financial Offi

    4/1/26 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    Cheetah Mobile Announces Fourth Quarter and Fiscal Year 2025 Unaudited Consolidated Financial Results

    AI and Others revenue grew 84.7% year over year and accounted for 46.5% of total revenue in 2025BEIJING, March 24, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE:CMCM), a China-based IT company with a commitment to AI innovation, today announced its unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2025. Full Year 2025 Financial HighlightsTotal revenues increased by 42.6% year over year to RMB 1,150.4 million (US$164.5 million) in 2025, driven by strong expansion across business segments.Revenue from the Internet business increased by 19.0% year over year to RMB 615.3 million (US$88.0 million) .Revenue from th

    3/24/26 4:30:00 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    Cheetah Mobile To Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 24, 2026

    BEIJING, March 19, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced that it will report its financial results for the fourth quarter and fiscal year 2025 before the U.S. market opens on Tuesday, March 24, 2026. The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com. Cheetah Mobile's management will hold an earnings conference call at 7:00 AM on Tuesday, March 24, 2026, U.S. Eastern Time (7:00 PM on Tuesday, March 24, 2026, Beijing Time/Hong Kong Time).Participants may access the call by dialing the following numbers:Main Line

    3/19/26 9:00:00 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    $AEY
    $AKTS
    $BLBX
    $CETX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Minim Inc.

    SC 13D/A - MINIM, INC. (0001467761) (Subject)

    11/15/24 5:00:07 PM ET
    $MINM
    Telecommunications Equipment
    Utilities

    SEC Form SC 13G filed by Cemtrex Inc.

    SC 13G - CEMTREX INC (0001435064) (Subject)

    11/14/24 5:51:51 PM ET
    $CETX
    Electrical Products
    Technology

    Amendment: SEC Form SC 13G/A filed by Akoustis Technologies Inc.

    SC 13G/A - Akoustis Technologies, Inc. (0001584754) (Subject)

    11/12/24 1:34:05 PM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care